483
Vistin Pharma AS avd Kragero FikkjebakkeVistin Pharma AS avd Kragero Fikkjebakke – FDA 483, Jan 31, 2025
Record Details
An FDA inspection of Vistin Pharma, an API manufacturer in Samidal, Norway, revealed significant deficiencies in their quality system. Observations included inadequate deviation investigations and corrective actions, insufficient testing of recycled solvents used in drug substance production, and a lack of written procedures for reporting product quality defects, specifically Field Alert Reports, to health authorities within specified timelines.
View Company Profile
ID · 6c706c1d-6343-4892-b80c-3040e3d034c1
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.